Rational design of highly selective spleen tyrosine kinase inhibitors
about
Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free-Energy Perturbation (FEP)Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugsSelective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation.3-aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors.A combined experimental and computational study of Vam3, a derivative of resveratrol, and Syk interaction.Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models.Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).Crystal Structures of Spleen Tyrosine Kinase in Complex with Two Novel 4-Aminopyrido[4,3-d] Pyrimidine Derivative Inhibitors.
P2860
Q27702174-E77068A3-9EF2-4C2E-92B3-43419AC01BF2Q27726998-8B13E054-1DE5-44A7-A707-8D35D1544478Q35055978-0960C91C-39C7-4507-854E-339782C5E5B6Q35434205-023E8F7E-5FD2-416D-93CE-2EB7ACE16759Q38655324-A2271095-C2C1-4B40-83CF-177DC650D6F1Q38766412-856C90D4-0A3A-483E-A4BE-B041F7BE3FCFQ39122968-893B75A8-2889-499C-A2E9-FE3E000F9B42Q51632843-C92D5BA3-D5B3-4155-9F53-913C9AC51B28Q54172917-E8421AA6-8814-4556-9C13-C328BB32C641Q54976524-A00C59C1-2591-4FDA-B958-121E74018F01
P2860
Rational design of highly selective spleen tyrosine kinase inhibitors
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rational design of highly selective spleen tyrosine kinase inhibitors
@ast
Rational design of highly selective spleen tyrosine kinase inhibitors
@en
Rational design of highly selective spleen tyrosine kinase inhibitors
@nl
type
label
Rational design of highly selective spleen tyrosine kinase inhibitors
@ast
Rational design of highly selective spleen tyrosine kinase inhibitors
@en
Rational design of highly selective spleen tyrosine kinase inhibitors
@nl
prefLabel
Rational design of highly selective spleen tyrosine kinase inhibitors
@ast
Rational design of highly selective spleen tyrosine kinase inhibitors
@en
Rational design of highly selective spleen tyrosine kinase inhibitors
@nl
P2093
P356
P1476
Rational design of highly selective spleen tyrosine kinase inhibitors
@en
P2093
Armando G Villaseñor
Cheng Liao
David M Goldstein
Fernando Padilla
Johannes C Hermann
Jutta Wanner
Kin Chun Luk
Matthew C Lucas
Michelle Slade
Wenjian Liu
P304
P356
10.1021/JM301367C
P407
P577
2012-12-13T00:00:00Z